Close

BIO Releases First Report in a Series on the State of Innovation in Highly Prevalent Chronic Diseases

First-of-its-kind report highlights the need to stimulate development efforts for depression therapeutics.   Washington, DC (January 18, 2018) – Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases: Depression Therapeutics, the first in a series on the current funding and R&D land scape for drugs to treat highly prevalent, chronic diseases. 

FDA Commissioner, Dr. Scott Gottlieb, to Address BIO Patient and Health Advocacy Summit

The head of the United States Food and Drug Administration, Dr. Scott Gottlieb, will be the keynote speaker at the BIO Patient and Health Advocacy Summit, October 2-3 at the Mayflower Hotel in Washington, DC. The annual event brings together attendees representing patient advocacy groups, health care providers, academia, government, think tanks, professional societies and the biotechnology industry and provides a forum for lively discussions on timely health policy issues and best practices. 

BIO Applauds Signing of Food and Drug Administration Reauthorization Act (FDARA)

Enactment of FDA User Fee package important victory for patients, medical innovation

Dr. Jeremy Levin (Ovid Therapeutics) at the 2017 BIO International Convention

Mike Huckman interviews Dr. Jeremy Levin (Ovid Therapeutics) at the 2017 BIO International Convention Buzz Center.

Nima Farzan (PaxVax) at the 2017 BIO International Convention

Mike Huckman interviews Nima Farzan (PaxVax) at the 2017 BIO International Convention Buzz Center.

Khyati Roberts (Abbvie) at the 2017 BIO International Convention

Mike Huckman interviews Khyati Roberts (Abbvie) at the 2017 BIO International Convention Buzz Center.

T.J. Sharpe at the 2017 BIO International Convention

Mike Huckman interviews T.J. Sharpe at the 2017 BIO International Convention Buzz Center.

Jay P. Siegel, MD (Johnson & Johnson) at the 2017 BIO International Convention

Mike Huckman interviews Jay P. Siegel, MD (Johnson & Johnson) at the 2017 BIO International Convention Buzz Center.

Rowan Chapman (Johnson & Johnson) at the 2017 BIO International Convention

Mike Huckman interviews Rowan Chapman (Johnson & Johnson) at the 2017 BIO International Convention Buzz Center.

Daniel Skovronsky (Eli Lilly and Company) at the 2017 BIO International Convention

Mike Huckman interviews Daniel Skovronsky (Eli Lilly and Company) at the 2017 BIO International Convention Buzz Center.